# Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

> **NCT00699322** · PHASE4 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 36 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT00699322
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699322, "Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00699322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*